FDA Approved: EZETIMIBE AND SIMVASTATIN — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approves Glenmark's ezetimibe and simvastatin as an original ANDA application, enabling generic availability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• EZETIMIBE AND SIMVASTATIN (ezetimibe and simvastatin)

Snippet

ORIG AP for EZETIMIBE AND SIMVASTATIN (EZETIMIBE AND SIMVASTATIN)